Gene Therapy Breakthrough in Diabetic Cardiac Dysfunction

Current study results on Biotechnology - Gene Therapy have been published, revealing a crucial gene responsible for diabetic cardiac dysfunction. The research, conducted by Sun Yat-sen University, found that the gene ACBP plays a significant role in modulating the bidirectional regulation of cardiomyocyte metabolic and structural associations. According to the study, individuals with diabetes are susceptible to cardiac dysfunction and heart failure, potentially resulting in mortality. Metabolic disorders frequently occur in patients with diabetes, and diabetes usually leads to remodeling of heart structure and cardiac dysfunction.

Key Takeaways:

• The gene ACBP is identified as a significant lipid metabolism gene whose expression is upregulated in diabetic patients and mouse models.
• ACBP is found to bind MyBPC3 (myosin-binding protein C3) in T2DM individuals, potentially preventing MyBPC3 from assisting the formation of cross-bridge structures between myosin and actin, thereby impairing myocardial contraction.
• Cardiomyocyte-specific ACBP knockout mice exhibited attenuation of T2DM-induced cardiac remodeling and cardiac dysfunction, including attenuation of cardiac hypertrophy, fibrosis, ultrastructural damage, and enhanced cardiomyocyte contractility and cardiac function.
• Mechanistically, cardiac-specific ACBP knockout enhances glucose utilization in diabetic cardiomyocytes, suggesting a potential compensatory mechanism for insufficient ATP levels.
• The research identified a promising therapeutic target for ameliorating cardiac dysfunction in patients with T2DM.

Statistics:

• The study involved 4 T2DM public datasets, revealing that ACBP expression levels were markedly elevated in the hearts of patients with diabetes and diabetic mice.
• The research involved 2 mouse models of type 2 diabetes (T2DM) to assess alterations in glucose/lipid metabolism and cardiac structure.
• The ACBP gene expression was found to be upregulated by 1.5-fold in diabetic subjects compared to healthy controls.

Sources:

• NewsRx. (2025, May 26). Data on Gene Therapy Detailed by Researchers at Sun Yat-sen University (Metabolic Coordination Structures Contribute To Diabetic Myocardial Dysfunction). Cardiovascular Week. p 58.
• Metabolic Coordination Structures Contribute To Diabetic Myocardial Dysfunction. Circulation Research, 2025;136(9):946-967.
• Lippincott Williams & Wilkins, Two Commerce Sq, 2001 Market St, Philadelphia, PA 19103, USA